{
    "clean_data": "VP OF BUSINESS DEVELOPMENT Professional Overview Accomplished Business Development executive with 7 years of experience in life science startups and clinical research organizations I also have an entrepreneurial spirit as the co founder of data analytics company and a financial background through my Master s at Bentley University Education December 2012 Finance McCallum Graduate School at Bentley University Finance Extensive case based exercises in capital budgeting corporate finance marketing sizing equities bonds common financial covenants and options Experience in valuations including risk adjusted net present value using WACC and CAPM and comparables May 2011 Bachelor of Science Economics Finance Bentley University Cum Laude Economics Finance Experience 01 2016 to Current VP of Business Development Company Name City State PainQx PQX is a diagnostic software company that developed a next generation approach to objectively measure pain in humans by decoding neural activity Incorporated the PQX platform in six clinical trials to be used as a pain biomarker to gauge the efficacy of experimental therapeutics Raised 500k from angel groups and venture funds Identified a joint venture partner in China leading to a 1M investment Developed an economic model demonstrating that the PQX technology reduces costs to health care providers by converting poorly managed pain patients to well managed pain patients saving up to 8 500 per patient Created financials statements including an income statement balance sheet and cash flow to justify capital raise and share with investors Centralized contacts alliances and investors into a CRM system streamlining the business development Developed all investor facing and business development presentations Formed a strategic alliance with Evoke Neurosciences to incorporate their EEG headset into the PainQx platform providing a turnkey solution to clinical research sponsors Coordinated bottoms upmarket survey that interviewed 100 physicians to validate the PainQx value proposition and identify new markets for the platform Sourced pitched and won a grant by the National Institue on Drug Abuse NIDA recognizing PainQx as one of 10 companies national that could address the opioid epidemic Put together a SBIR Fast Track Application to be reviewed by NIDA 06 2012 to 01 2016 Co Founder VP of Business Development Company Name City State LSN tracks the funding and partnering preferences of 5 000 investors and strategic partners by actively interviewing them on a 90 day rolling cycle This information allows entrepreneurs to identify investors and strategic that meet their fundraising and partnering needs Since inception LSN has generated 4M in revenue with 2016 revenue of 3M In 2015 LSN launched a broker dealer Boston Innovation Capital to execute fundraising campaigns between 5M 20M Oversee all aspects of operation such as sales financial projections IT management and marketing Grew the LSN team to 22 employees 7 business development representatives 6 researchers 4 conference representatives and 2 marketers Created pitch decks executive summaries and websites for twelve biotech medtech companies resulting in increased investor responsiveness Utilize SalesForce com to host LSN s back end data and linked it with an established graphical user interface saving over 1M in R D costs Deep knowledge of database and information systems including profile structuring data segmentation and aggregation and filtering Personally sourced pitched and closed over 1M in consulting and data services from Big Pharma CROs and emerging biotech medtech companies Helped create fundraising strategy for thirty four biotech medtech companies including EIP Pharma Hsiri Therapeutics and JB Therapeutics Corbus Pharma Built personal network of over 1 000 life science investors life science entrepreneurs investment banks family offices and big pharma med tech executives 02 2011 to 07 2012 Abpro specializes in the generation of custom monoclonal antibodies The foundation of Abpro s techn Company Name City State Abpro specializes in the generation of custom monoclonal antibodies The foundation of Abpro s technology is the HTP platform a genetically engineered mouse with a boosted immune system enabling the mouse to have a broader epitope spread facilitating the generation of antibodies to traditionally difficult targets such as GPCR s and 100 homologous target Personally closed 1 6M in new business revenue Part of a business development team that grew sales from 700 000 in 2010 to 2 2M in 2011 and 4 0M in 2012 Participated in a financing campaign that aimed to raise 3 4M in debt from various banks and mezzanine debt funds Modeled the present value of debt based offerings to provide investment decisions to upper management Developed the company s first financial model that tied together income balance sheet and cash flow statements This model was used to plan the future financing needs as well as develop the company s long term budgetary constraints Built and implemented an inventory tracking system to streamline operations leading to a 30 reduction in production delays Created an automated system that crawled three hundred scientific journals gathering contact information of authors This information led to the creation of database of 100 000 contacts for use as a targeted email campaign Interests USA 14 years London 6 years Colombia 5 years China 2 years Languages Native Speaker in English and Spanish Skills streamline approach balance sheet bonds budgeting business development cash flow clinical research clinical trials com consulting corporate finance CRM database email English equities Fast financials financing financial fundraising funds graphical user interface information systems Innovation inventory marketing network neural next presentations Speaker sales scientific Spanish strategy strategic websites Additional Information International Experience USA 14 years London 6 years Colombia 5 years China 2 years",
    "entities": [
        "Additional Information International Experience USA",
        "PQX",
        "NIDA",
        "Interests USA",
        "Evoke Neurosciences",
        "Bentley University",
        "CAPM",
        "Created",
        "WACC",
        "China",
        "Abpro",
        "Business Development Company Name City State LSN",
        "GPCR",
        "Coordinated",
        "Bentley University Finance Extensive",
        "the National Institue on Drug Abuse NIDA",
        "Colombia",
        "London",
        "JB Therapeutics Corbus Pharma Built",
        "Cum Laude Economics Finance",
        "Built",
        "Put",
        "Boston Innovation Capital",
        "LSN",
        "EIP Pharma Hsiri Therapeutics",
        "VP OF BUSINESS DEVELOPMENT Professional Overview Accomplished Business Development",
        "EEG",
        "Current VP of Business Development Company Name City State PainQx",
        "Centralized",
        "HTP"
    ],
    "experience": "Education December 2012 Finance McCallum Graduate School at Bentley University Finance Extensive case based exercises in capital budgeting corporate finance marketing sizing equities bonds common financial covenants and options Experience in valuations including risk adjusted net present value using WACC and CAPM and comparables May 2011 Bachelor of Science Economics Finance Bentley University Cum Laude Economics Finance Experience 01 2016 to Current VP of Business Development Company Name City State PainQx PQX is a diagnostic software company that developed a next generation approach to objectively measure pain in humans by decoding neural activity Incorporated the PQX platform in six clinical trials to be used as a pain biomarker to gauge the efficacy of experimental therapeutics Raised 500k from angel groups and venture funds Identified a joint venture partner in China leading to a 1 M investment Developed an economic model demonstrating that the PQX technology reduces costs to health care providers by converting poorly managed pain patients to well managed pain patients saving up to 8 500 per patient Created financials statements including an income statement balance sheet and cash flow to justify capital raise and share with investors Centralized contacts alliances and investors into a CRM system streamlining the business development Developed all investor facing and business development presentations Formed a strategic alliance with Evoke Neurosciences to incorporate their EEG headset into the PainQx platform providing a turnkey solution to clinical research sponsors Coordinated bottoms upmarket survey that interviewed 100 physicians to validate the PainQx value proposition and identify new markets for the platform Sourced pitched and won a grant by the National Institue on Drug Abuse NIDA recognizing PainQx as one of 10 companies national that could address the opioid epidemic Put together a SBIR Fast Track Application to be reviewed by NIDA 06 2012 to 01 2016 Co Founder VP of Business Development Company Name City State LSN tracks the funding and partnering preferences of 5 000 investors and strategic partners by actively interviewing them on a 90 day rolling cycle This information allows entrepreneurs to identify investors and strategic that meet their fundraising and partnering needs Since inception LSN has generated 4 M in revenue with 2016 revenue of 3 M In 2015 LSN launched a broker dealer Boston Innovation Capital to execute fundraising campaigns between 5 M 20 M Oversee all aspects of operation such as sales financial projections IT management and marketing Grew the LSN team to 22 employees 7 business development representatives 6 researchers 4 conference representatives and 2 marketers Created pitch decks executive summaries and websites for twelve biotech medtech companies resulting in increased investor responsiveness Utilize SalesForce com to host LSN s back end data and linked it with an established graphical user interface saving over 1 M in R D costs Deep knowledge of database and information systems including profile structuring data segmentation and aggregation and filtering Personally sourced pitched and closed over 1 M in consulting and data services from Big Pharma CROs and emerging biotech medtech companies Helped create fundraising strategy for thirty four biotech medtech companies including EIP Pharma Hsiri Therapeutics and JB Therapeutics Corbus Pharma Built personal network of over 1 000 life science investors life science entrepreneurs investment banks family offices and big pharma med tech executives 02 2011 to 07 2012 Abpro specializes in the generation of custom monoclonal antibodies The foundation of Abpro s techn Company Name City State Abpro specializes in the generation of custom monoclonal antibodies The foundation of Abpro s technology is the HTP platform a genetically engineered mouse with a boosted immune system enabling the mouse to have a broader epitope spread facilitating the generation of antibodies to traditionally difficult targets such as GPCR s and 100 homologous target Personally closed 1 6 M in new business revenue Part of a business development team that grew sales from 700 000 in 2010 to 2 2 M in 2011 and 4 0 M in 2012 Participated in a financing campaign that aimed to raise 3 4 M in debt from various banks and mezzanine debt funds Modeled the present value of debt based offerings to provide investment decisions to upper management Developed the company s first financial model that tied together income balance sheet and cash flow statements This model was used to plan the future financing needs as well as develop the company s long term budgetary constraints Built and implemented an inventory tracking system to streamline operations leading to a 30 reduction in production delays Created an automated system that crawled three hundred scientific journals gathering contact information of authors This information led to the creation of database of 100 000 contacts for use as a targeted email campaign Interests USA 14 years London 6 years Colombia 5 years China 2 years Languages Native Speaker in English and Spanish Skills streamline approach balance sheet bonds budgeting business development cash flow clinical research clinical trials com consulting corporate finance CRM database email English equities Fast financials financing financial fundraising funds graphical user interface information systems Innovation inventory marketing network neural next presentations Speaker sales scientific Spanish strategy strategic websites Additional Information International Experience USA 14 years London 6 years Colombia 5 years China 2 years",
    "extracted_keywords": [
        "VP",
        "BUSINESS",
        "DEVELOPMENT",
        "Professional",
        "Overview",
        "Accomplished",
        "Business",
        "Development",
        "executive",
        "years",
        "experience",
        "life",
        "science",
        "startups",
        "research",
        "organizations",
        "spirit",
        "co",
        "founder",
        "data",
        "analytics",
        "company",
        "background",
        "Master",
        "Bentley",
        "University",
        "Education",
        "December",
        "Finance",
        "McCallum",
        "Graduate",
        "School",
        "Bentley",
        "University",
        "Finance",
        "Extensive",
        "case",
        "exercises",
        "capital",
        "budgeting",
        "finance",
        "marketing",
        "equities",
        "bonds",
        "covenants",
        "options",
        "Experience",
        "valuations",
        "risk",
        "value",
        "WACC",
        "CAPM",
        "May",
        "Bachelor",
        "Science",
        "Economics",
        "Finance",
        "Bentley",
        "University",
        "Cum",
        "Laude",
        "Economics",
        "Finance",
        "Experience",
        "VP",
        "Business",
        "Development",
        "Company",
        "Name",
        "City",
        "State",
        "PainQx",
        "PQX",
        "software",
        "company",
        "generation",
        "approach",
        "pain",
        "humans",
        "activity",
        "PQX",
        "platform",
        "trials",
        "pain",
        "biomarker",
        "efficacy",
        "therapeutics",
        "500k",
        "angel",
        "groups",
        "venture",
        "funds",
        "venture",
        "partner",
        "China",
        "M",
        "investment",
        "model",
        "demonstrating",
        "PQX",
        "technology",
        "costs",
        "health",
        "care",
        "providers",
        "pain",
        "patients",
        "pain",
        "patients",
        "patient",
        "financials",
        "statements",
        "income",
        "statement",
        "balance",
        "sheet",
        "cash",
        "flow",
        "capital",
        "raise",
        "investors",
        "contacts",
        "alliances",
        "investors",
        "CRM",
        "system",
        "business",
        "development",
        "investor",
        "facing",
        "business",
        "development",
        "presentations",
        "alliance",
        "Evoke",
        "Neurosciences",
        "EEG",
        "headset",
        "PainQx",
        "platform",
        "turnkey",
        "solution",
        "research",
        "sponsors",
        "bottoms",
        "upmarket",
        "survey",
        "physicians",
        "PainQx",
        "value",
        "proposition",
        "markets",
        "platform",
        "grant",
        "National",
        "Institue",
        "Drug",
        "Abuse",
        "NIDA",
        "PainQx",
        "companies",
        "epidemic",
        "SBIR",
        "Fast",
        "Track",
        "Application",
        "NIDA",
        "Co",
        "Founder",
        "VP",
        "Business",
        "Development",
        "Company",
        "Name",
        "City",
        "State",
        "LSN",
        "funding",
        "partnering",
        "preferences",
        "investors",
        "partners",
        "day",
        "rolling",
        "cycle",
        "information",
        "entrepreneurs",
        "investors",
        "fundraising",
        "partnering",
        "needs",
        "inception",
        "LSN",
        "M",
        "revenue",
        "revenue",
        "M",
        "LSN",
        "broker",
        "dealer",
        "Boston",
        "Innovation",
        "Capital",
        "fundraising",
        "campaigns",
        "M",
        "M",
        "aspects",
        "operation",
        "sales",
        "projections",
        "IT",
        "management",
        "marketing",
        "LSN",
        "team",
        "employees",
        "business",
        "development",
        "representatives",
        "researchers",
        "conference",
        "representatives",
        "marketers",
        "pitch",
        "decks",
        "summaries",
        "websites",
        "companies",
        "investor",
        "responsiveness",
        "Utilize",
        "SalesForce",
        "com",
        "LSN",
        "end",
        "data",
        "user",
        "interface",
        "M",
        "R",
        "D",
        "knowledge",
        "database",
        "information",
        "systems",
        "profile",
        "data",
        "segmentation",
        "aggregation",
        "filtering",
        "Personally",
        "M",
        "consulting",
        "data",
        "services",
        "Big",
        "Pharma",
        "CROs",
        "medtech",
        "companies",
        "fundraising",
        "strategy",
        "medtech",
        "companies",
        "EIP",
        "Pharma",
        "Hsiri",
        "Therapeutics",
        "JB",
        "Therapeutics",
        "Corbus",
        "Pharma",
        "network",
        "life",
        "science",
        "investors",
        "life",
        "science",
        "entrepreneurs",
        "investment",
        "banks",
        "family",
        "offices",
        "pharma",
        "med",
        "tech",
        "executives",
        "Abpro",
        "generation",
        "custom",
        "monoclonal",
        "foundation",
        "Abpro",
        "Company",
        "Name",
        "City",
        "State",
        "Abpro",
        "generation",
        "custom",
        "monoclonal",
        "foundation",
        "Abpro",
        "technology",
        "HTP",
        "platform",
        "mouse",
        "system",
        "mouse",
        "epitope",
        "generation",
        "targets",
        "GPCR",
        "s",
        "target",
        "M",
        "business",
        "revenue",
        "Part",
        "business",
        "development",
        "team",
        "sales",
        "M",
        "M",
        "financing",
        "campaign",
        "M",
        "debt",
        "banks",
        "debt",
        "funds",
        "value",
        "debt",
        "offerings",
        "investment",
        "decisions",
        "management",
        "company",
        "model",
        "income",
        "balance",
        "sheet",
        "cash",
        "flow",
        "statements",
        "model",
        "financing",
        "company",
        "term",
        "constraints",
        "inventory",
        "tracking",
        "system",
        "operations",
        "reduction",
        "production",
        "delays",
        "system",
        "journals",
        "contact",
        "information",
        "authors",
        "information",
        "creation",
        "database",
        "contacts",
        "use",
        "email",
        "campaign",
        "Interests",
        "USA",
        "years",
        "London",
        "years",
        "Colombia",
        "years",
        "China",
        "years",
        "Languages",
        "Native",
        "Speaker",
        "English",
        "Spanish",
        "Skills",
        "approach",
        "balance",
        "sheet",
        "bonds",
        "business",
        "development",
        "cash",
        "flow",
        "research",
        "trials",
        "com",
        "finance",
        "CRM",
        "database",
        "email",
        "equities",
        "financials",
        "fundraising",
        "funds",
        "user",
        "interface",
        "information",
        "systems",
        "Innovation",
        "inventory",
        "marketing",
        "network",
        "presentations",
        "Speaker",
        "sales",
        "strategy",
        "websites",
        "Additional",
        "Information",
        "International",
        "Experience",
        "USA",
        "years",
        "London",
        "years",
        "Colombia",
        "years",
        "China",
        "years"
    ],
    "input_field": null,
    "instruction": "",
    "processed_at": "2024-11-24T19:33:36.787006",
    "resume_data": "VP OF BUSINESS DEVELOPMENT Professional Overview Accomplished Business Development executive with 7 years of experience in life science startups and clinical research organizations I also have an entrepreneurial spirit as the co founder of data analytics company and a financial background through my Master s at Bentley University Education December 2012 Finance McCallum Graduate School at Bentley University Finance Extensive case based exercises in capital budgeting corporate finance marketing sizing equities bonds common financial covenants and options Experience in valuations including risk adjusted net present value using WACC and CAPM and comparables May 2011 Bachelor of Science Economics Finance Bentley University Cum Laude Economics Finance Experience 01 2016 to Current VP of Business Development Company Name City State PainQx PQX is a diagnostic software company that developed a next generation approach to objectively measure pain in humans by decoding neural activity Incorporated the PQX platform in six clinical trials to be used as a pain biomarker to gauge the efficacy of experimental therapeutics Raised 500k from angel groups and venture funds Identified a joint venture partner in China leading to a 1M investment Developed an economic model demonstrating that the PQX technology reduces costs to health care providers by converting poorly managed pain patients to well managed pain patients saving up to 8 500 per patient Created financials statements including an income statement balance sheet and cash flow to justify capital raise and share with investors Centralized contacts alliances and investors into a CRM system streamlining the business development Developed all investor facing and business development presentations Formed a strategic alliance with Evoke Neurosciences to incorporate their EEG headset into the PainQx platform providing a turnkey solution to clinical research sponsors Coordinated bottoms upmarket survey that interviewed 100 physicians to validate the PainQx value proposition and identify new markets for the platform Sourced pitched and won a grant by the National Institue on Drug Abuse NIDA recognizing PainQx as one of 10 companies national that could address the opioid epidemic Put together a SBIR Fast Track Application to be reviewed by NIDA 06 2012 to 01 2016 Co Founder VP of Business Development Company Name City State LSN tracks the funding and partnering preferences of 5 000 investors and strategic partners by actively interviewing them on a 90 day rolling cycle This information allows entrepreneurs to identify investors and strategic that meet their fundraising and partnering needs Since inception LSN has generated 4M in revenue with 2016 revenue of 3M In 2015 LSN launched a broker dealer Boston Innovation Capital to execute fundraising campaigns between 5M 20M Oversee all aspects of operation such as sales financial projections IT management and marketing Grew the LSN team to 22 employees 7 business development representatives 6 researchers 4 conference representatives and 2 marketers Created pitch decks executive summaries and websites for twelve biotech medtech companies resulting in increased investor responsiveness Utilize SalesForce com to host LSN s back end data and linked it with an established graphical user interface saving over 1M in R D costs Deep knowledge of database and information systems including profile structuring data segmentation and aggregation and filtering Personally sourced pitched and closed over 1M in consulting and data services from Big Pharma CROs and emerging biotech medtech companies Helped create fundraising strategy for thirty four biotech medtech companies including EIP Pharma Hsiri Therapeutics and JB Therapeutics Corbus Pharma Built personal network of over 1 000 life science investors life science entrepreneurs investment banks family offices and big pharma med tech executives 02 2011 to 07 2012 Abpro specializes in the generation of custom monoclonal antibodies The foundation of Abpro s techn Company Name City State Abpro specializes in the generation of custom monoclonal antibodies The foundation of Abpro s technology is the HTP platform a genetically engineered mouse with a boosted immune system enabling the mouse to have a broader epitope spread facilitating the generation of antibodies to traditionally difficult targets such as GPCR s and 100 homologous target Personally closed 1 6M in new business revenue Part of a business development team that grew sales from 700 000 in 2010 to 2 2M in 2011 and 4 0M in 2012 Participated in a financing campaign that aimed to raise 3 4M in debt from various banks and mezzanine debt funds Modeled the present value of debt based offerings to provide investment decisions to upper management Developed the company s first financial model that tied together income balance sheet and cash flow statements This model was used to plan the future financing needs as well as develop the company s long term budgetary constraints Built and implemented an inventory tracking system to streamline operations leading to a 30 reduction in production delays Created an automated system that crawled three hundred scientific journals gathering contact information of authors This information led to the creation of database of 100 000 contacts for use as a targeted email campaign Interests USA 14 years London 6 years Colombia 5 years China 2 years Languages Native Speaker in English and Spanish Skills streamline approach balance sheet bonds budgeting business development cash flow clinical research clinical trials com consulting corporate finance CRM database email English equities Fast financials financing financial fundraising funds graphical user interface information systems Innovation inventory marketing network neural next presentations Speaker sales scientific Spanish strategy strategic websites Additional Information International Experience USA 14 years London 6 years Colombia 5 years China 2 years",
    "unique_id": "9ce48dfe-ec2c-4efc-9571-da81ca8fb0bd"
}